Fibromyalgia is a chronic condition characterised by widespread musculoskeletal pain that is notoriously difficult to manage with conventional therapies. For patients who have exhausted standard treatment options without adequate relief, a private specialist may be able to prescribe cannabis-based medicines as part of a broader pain management strategy.
Fibromyalgia is a long-term condition that causes pain all over the body, often accompanied by fatigue, sleep problems, cognitive difficulties (sometimes called "fibro fog"), headaches, irritable bowel syndrome (IBS), and heightened sensitivity to pain. In the UK, fibromyalgia is recognised by the NHS as a real and significant condition, though its underlying mechanisms remain incompletely understood.
The condition is more commonly diagnosed in women than men and often emerges in middle age, though it can affect people of any age. Fibromyalgia is characterised by central sensitisation: the central nervous system amplifies pain signals, making normal stimuli feel painful. Standard treatment approaches include aerobic exercise, cognitive behavioural therapy, low-dose antidepressants (amitriptyline or duloxetine), and gabapentinoids (pregabalin). Many patients find these help manage symptoms but do not eliminate them.
The evidence base for cannabis-based medicines in fibromyalgia is growing, with observational studies from programmes in Canada and Israel suggesting that a meaningful proportion of fibromyalgia patients report improvements in pain, sleep, and quality of life following treatment. There is a plausible biological rationale given the role of the endocannabinoid system in central pain processing and sleep regulation — two of the primary areas of dysfunction in fibromyalgia.
Despite this emerging evidence, randomised controlled trials specifically in fibromyalgia populations remain limited, and UK clinical guidelines do not currently include cannabis-based medicines as a standard recommendation. Specialist prescribing for fibromyalgia is therefore considered on an individual clinical basis, for patients who have not responded to established evidence-based treatments.
At a consultation for fibromyalgia, the specialist will take a detailed history of your pain — its distribution, severity, quality, and impact on sleep, fatigue, and daily function. Products prescribed for fibromyalgia often include a balanced or CBD-dominant formulation, with THC introduced cautiously if needed for pain and sleep. Dosing is titrated gradually over several weeks, and a follow-up appointment allows the specialist to assess response.
The information on this page is provided for general educational purposes only and does not constitute medical advice. Eligibility for medical cannabis in the UK is determined by a licensed specialist on an individual clinical basis. Always consult a qualified healthcare professional about your own situation.